Oliver A. Zill, Ph.D. - Publications

Affiliations: 
Molecular & Cell Biology University of California, Berkeley, Berkeley, CA, United States 
Area:
Genetics, Genomics and Development

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mack PC, Banks KC, Espenschied CR, Burich RA, Zill OA, Lee CE, Riess JW, Mortimer SA, Talasaz A, Lanman RB, Gandara DR. Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases. Cancer. PMID 32365229 DOI: 10.1002/Cncr.32876  0.399
2018 Zill OA, Banks KC, Fairclough SR, Mortimer S, Vowles JV, Mokhtari R, Gandara DR, Mack PC, Odegaard JI, Nagy RJ, Baca AM, Eltoukhy H, Chudova DI, Lanman RB, Talasaz A. The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29776953 DOI: 10.1158/1078-0432.Ccr-17-3837  0.44
2018 Fairclough S, Zill O, Barbacioru C, Odegaard J, Lanman RB, Talasaz A, Chudova D. Abstract 2190: A method for differentiating clonal driver mutations from subclonal emerging resistance mutations in circulating cell-free DNA Tumor Biology. DOI: 10.1158/1538-7445.Am2018-2190  0.324
2017 Mack P, Banks K, Riess J, Zill O, Mortimer S, Chudova D, Odegaard J, Lee C, Nagy R, Eltoukhy H, Talasaz A, Lanman R, Gandara DR. OA06.01 Clinical Utility of Circulating Tumor DNA (ctDNA) Analysis by Digital next Generation Sequencing of over 5,000 Advanced NSCLC Patients Journal of Thoracic Oncology. 12: S263-S264. DOI: 10.1016/J.Jtho.2016.11.256  0.369
2016 Zill OA, Mortimer S, Banks KC, Nagy RJ, Chudova D, Jackson C, Baca A, Ye JZ, Lanman RB, Talasaz A, Eltoukhy H, Kurzrock R. Somatic genomic landscape of over 15,000 patients with advanced-stage cancer from clinical next-generation sequencing analysis of circulating tumor DNA. Journal of Clinical Oncology. 34: LBA11501-LBA11501. DOI: 10.1200/Jco.2016.34.18_Suppl.Lba11501  0.41
2016 Fairclough SR, Zill OA, Chudova D, Lee CE, Lanman RB, Banks KC, Nagy RJ, Mortimer S, Eltoukhy H, Talasaz A, Ramalingam SS. Case series of EGFR C797S mutations in non-small cell lung cancer identified with cell-free circulating tumor DNA next generation sequencing. Journal of Clinical Oncology. 34: e23021-e23021. DOI: 10.1200/Jco.2016.34.15_Suppl.E23021  0.352
2016 Austin L, Jaslow R, Fortina P, Nagy R, Zill O, Talasaz A, Cristofanilli M. Abstract P6-03-06: Circulating tumor DNA (ctDNA) for detection of molecular residual disease (MoRD) in breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-03-06  0.343
2016 Zill OA, Banks KC, Jackson C, Mortimer S, Baca A, Nagy B, Lanman RB, Eltoukhy H, AT. Abstract 4343: Comparison of over 10,000 clinical NGS circulating tumor DNA profiles to tissue-derived genomic compendia Cancer Research. 76: 4343-4343. DOI: 10.1158/1538-7445.Am2016-4343  0.451
2016 Austin L, Nagy R, Zill O, Lanman RB, Talasaz A, Cristofanilli M. Abstract 172: Managing metastatic breast cancer via serial monitoring with circulating cell-free tumor DNA next generation sequencing testing Cancer Research. 76: 172-172. DOI: 10.1158/1538-7445.Am2016-172  0.414
2015 Lanman RB, Mortimer SA, Zill OA, Sebisanovic D, Lopez R, Blau S, Collisson EA, Divers SG, Hoon DS, Kopetz ES, Lee J, Nikolinakos PG, Baca AM, Kermani BG, Eltoukhy H, et al. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA. Plos One. 10: e0140712. PMID 26474073 DOI: 10.1371/Journal.Pone.0140712  0.475
2015 Kim ST, Lee WS, Lanman RB, Mortimer S, Zill OA, Kim KM, Jang KT, Kim SH, Park SH, Park JO, Park YS, Lim HY, Eltoukhy H, Kang WK, Lee WY, et al. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients. Oncotarget. PMID 26452027 DOI: 10.18632/Oncotarget.5465  0.46
2015 Zill OA, Greene C, Sebisanovic D, Siew L, Leng J, Vu M, Hendifar AE, Wang Z, Atreya CE, Kelley RK, Van Loon K, Ko AH, Tempero MA, Bivona TG, Munster PN, et al. Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas. Cancer Discovery. PMID 26109333 DOI: 10.1158/2159-8290.Cd-15-0274  0.412
2015 Collisson EA, Zill O, Greene C, Leng J, Siew L, Vu MA, Kelley RK, Ko AH, Atreya CE, Van Loon K, Bivona TG, Tempero MA, Sebisanovic D, Munster PN, Talasaz A. Prospective evaluation of circulating tumor DNA sequencing in pancreatobiliary carcinomas. Journal of Clinical Oncology. 33: 107-107. DOI: 10.1200/Jco.2015.33.15_Suppl.107  0.321
2015 Mileham KF, Zhang Q, Farhangfar CJ, Haggstrom DE, Fairclough S, Zill OA, Carrizosa DR, Lanman RB, Kim ES. Abstract C80: Development of EGFR C797S mutation in serial liquid biopsy assessments in the clinical practice setting Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C80  0.35
2015 Banks KC, Mortimer SAW, Zill OA, Lanman RB, Eltoukhy H, Talasaz A. Abstract B140: Genomic profiling of over 5,000 consecutive cancer patients with a CLIA-certified cell-free DNA NGS test: Analytic and clinical validity and utility Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B140  0.455
2012 Zill OA, Scannell DR, Kuei J, Sadhu M, Rine J. Evolutionary analysis of heterochromatin protein compatibility by interspecies complementation in Saccharomyces. Genetics. 192: 1001-14. PMID 22923378 DOI: 10.1534/Genetics.112.141549  0.621
2011 Scannell DR, Zill OA, Rokas A, Payen C, Dunham MJ, Eisen MB, Rine J, Johnston M, Hittinger CT. The Awesome Power of Yeast Evolutionary Genetics: New Genome Sequences and Strain Resources for the Saccharomyces sensu stricto Genus. G3 (Bethesda, Md.). 1: 11-25. PMID 22384314 DOI: 10.1534/G3.111.000273  0.615
2010 Zill OA, Scannell D, Teytelman L, Rine J. Co-evolution of transcriptional silencing proteins and the DNA elements specifying their assembly. Plos Biology. 8: e1000550. PMID 21151344 DOI: 10.1371/Journal.Pbio.1000550  0.623
2009 Teytelman L, Ozaydin B, Zill O, Lefrançois P, Snyder M, Rine J, Eisen MB. Impact of chromatin structures on DNA processing for genomic analyses. Plos One. 4: e6700. PMID 19693276 DOI: 10.1371/Journal.Pone.0006700  0.572
2008 Zill OA, Rine J. Interspecies variation reveals a conserved repressor of alpha-specific genes in Saccharomyces yeasts. Genes & Development. 22: 1704-16. PMID 18559484 DOI: 10.1101/Gad.1640008  0.543
Show low-probability matches.